NEW YORK--(BUSINESS WIRE)--Aspen Park Pharmaceuticals, Inc., a privately held therapeutics company focused on the development and commercialization of novel therapies for men’s health diseases and conditions, including male secondary hypogonadism, prostate cancer, and sexual dysfunction, today announced that it has raised Series A funding from a select group of New York based investors.
Help employers find you! Check out all the jobs and post your resume.
